VANGUARD GROUP INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$9,954,604
-24.4%
2,868,762
+1.4%
0.00%
Q2 2023$13,159,072
+2.6%
2,829,908
+1.9%
0.00%
Q1 2023$12,829,564
-40.0%
2,776,962
+5.0%
0.00%
-100.0%
Q4 2022$21,368,950
+87.8%
2,644,672
+29.0%
0.00%
Q3 2022$11,379,000
+7.2%
2,050,276
+0.6%
0.00%
Q2 2022$10,614,000
-42.1%
2,037,325
-8.7%
0.00%
Q1 2022$18,338,000
-41.8%
2,230,997
+5.3%
0.00%
-100.0%
Q4 2021$31,513,000
-21.1%
2,117,807
+0.1%
0.00%0.0%
Q3 2021$39,952,000
+4.2%
2,115,031
+2.5%
0.00%0.0%
Q2 2021$38,355,000
-17.4%
2,063,195
+1.1%
0.00%0.0%
Q1 2021$46,431,000
+11.2%
2,039,989
+6.0%
0.00%0.0%
Q4 2020$41,761,000
+219.7%
1,923,619
+48.0%
0.00%
Q3 2020$13,064,000
+68.5%
1,299,805
+30.1%
0.00%
Q2 2020$7,753,000
+101.0%
998,965
+164.2%
0.00%
Q1 2020$3,857,000
+3.0%
378,178
+11.0%
0.00%
Q4 2019$3,746,000
+27.5%
340,587
+5.3%
0.00%
Q3 2019$2,939,000
+32.3%
323,299
+65.6%
0.00%
Q2 2019$2,222,000
+10.4%
195,254
+10.5%
0.00%
Q1 2019$2,013,000
+79.6%
176,772
+42.2%
0.00%
Q4 2018$1,121,000124,2830.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$13,773,0003.47%
AJU IB Investment Co., Ltd. 175,000$1,439,0002.22%
Frazier Life Sciences Management, L.P. 1,776,479$14,603,0001.24%
First Light Asset Management, LLC 1,672,497$13,748,0001.21%
BVF INC/IL 3,447,946$28,342,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,732,400$30,680,0000.94%
Endurant Capital Management LP 296,508$2,437,0000.64%
Parkman Healthcare Partners LLC 199,846$1,643,0000.48%
Eventide Asset Management 2,708,975$22,268,0000.35%
Lombard Odier Asset Management (Switzerland) SA 391,024$3,214,0000.25%
View complete list of SUTRO BIOPHARMA INC shareholders